Ceragon Networks Ltd. (CRNT) Q1 2024 Earnings Call Transcript

SA Transcripts
153.96K Followers

Q1: 2024-05-07 Earnings Summary

EPS of $0.05 beats by $0.01
 | Revenue of $88.50M (6.10% Y/Y) beats by $1.09M

Ceragon Networks Ltd. (NASDAQ:CRNT) Q1 2024 Earnings Conference Call May 7, 2024 8:30 AM ET

Company Participants

Rob Fink - Head of IR
Doron Arazi - Chief Executive Officer
Ronen Stein - Chief Financial Officer

Conference Call Participants

Alex Henderson - Needham & Company
Rommel Dionisio - Aegis Capital
Jeff Rosenberg - Rail-Splitter Capital

Operator

Ladies and gentlemen, thank you for standing by and welcome to Ceragon Networks Conference Call. Our presentation today will be followed by a question-and-answer session. [Operator Instructions] I must advise you that this call is being recorded.

I'd now like to hand it over to Rob Fink, Head of Investor Relations. Please go ahead, sir.

Rob Fink

Thank you, operator, and good morning, everyone. Hosting today's call is Doron Arazi, Ceragon's Chief Executive Officer and Ronen Stein, Chief Financial Officer.

Before we start, I would like to note that certain statements made on this call including projected financial information, results and the company's future initiatives, future events, business outlook, development efforts and their potential outcome, anticipated progress and plans, results and timelines and other financial accounting related matters constitute forward-looking statements within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended and the safe harbor provisions and the Securities Litigation Reform Act of 1995.

Ceragon intends forward-looking terminology, such as believes, expects, may, will, should, anticipates, plans or similar expressions to identify forward-looking statements. Such statements reflect only current beliefs, expectations and assumptions of Ceragon's management. The actual results, performance or achievements of Ceragon may differ materially, as they are subject to certain risks and uncertainties, which could cause Ceragon's actual results to differ materially from those projected in such forward-looking statements. Such risks and uncertainties include, but are not limited to, risks and uncertainties that are described in Ceragon's most recent annual report on Form 20-F and may be supplemented

Recommended For You

About CRNT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CRNT